Items where authors include "Keen, R."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Moss, K.E. orcid.org/0000-0002-1944-8302, Keen, R. orcid.org/0009-0001-8216-3828, Fang, S. orcid.org/0009-0008-7019-5647 et al. (7 more authors) (2025) Mobility and quality of life in adults with paediatric-onset hypophosphatasia treated with Asfotase alfa: results from UK managed access agreement. Advances in Therapy, 42 (5). pp. 2429-2444. ISSN 0741-238X

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Berg, K., Dockrell, D., Colvin, L. et al. (15 more authors) (2024) Causes of musculoskeletal pain in Paget’s disease of bone. Calcified Tissue International, 115 (5). pp. 533-541. ISSN 0171-967X

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Kamenicky, P. orcid.org/0000-0002-1994-4226, Briot, K. orcid.org/0000-0002-6238-2601, Brandi, M.L. orcid.org/0000-0002-8741-0592 et al. (14 more authors) (2023) Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. RMD Open, 9 (1). e002676. ISSN 2056-5933

Orlando, G., Bubbear, J., Clarke, S. et al. (7 more authors) (2022) Physical function and physical activity in adults with X-linked hypophosphatemia. Osteoporosis International, 33 (7). pp. 1485-1491. ISSN 0937-941X

Harvey, N.C., Poole, K.E., Ralston, S.H. et al. (47 more authors) (2022) Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap. Archives of Osteoporosis, 17 (1). 12. ISSN 1862-3522

Quinlivan, R., Messer, B., Murphy, P. et al. (15 more authors) (2021) Adult North Star Network (ANSN): consensus guideline for the standard of care of adults with Duchenne muscular dystrophy. Journal of Neuromuscular Diseases, 8 (6). pp. 899-926. ISSN 2214-3599

Briot, K., Portale, A.A., Brandi, M.L. et al. (27 more authors) (2021) Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension. RMD Open, 7 (3). e001714. ISSN 2056-5933

Mickute, G., Staley, K., Delaney, H. et al. (15 more authors) (2020) Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance. Orphanet Journal of Rare Diseases, 15 (1). 117. ISSN 1750-1172

Panoutsopoulou, K., Southam, L., Elliott, K.S. et al. (73 more authors) (2010) Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Annals of the Rheumatic Diseases (ARD), 70 (5). pp. 864-867. ISSN 0003-4967